Moving marijuana from schedule I to schedule III of the uniform controlled substances act.
Summary
SB 484 would revise Kansas’s Uniform Controlled Substances Act to move marijuana and tetrahydrocannabinols from Schedule I to Schedule III. The bill amends the state’s controlled-substances schedules and related criminal possession statute so that marijuana and tetrahydrocannabinols are treated less severely than other Schedule I drugs. It also updates cross-references and repeals the existing versions of the affected sections.
Under the bill, possession of marijuana or tetrahydrocannabinols would no longer be handled as a Schedule I possession offense. Instead, the bill places those substances into the Schedule III framework, which changes the criminal classification for possession and the way prior convictions are counted for repeat-offender treatment. The bill also preserves existing exceptions and affirmative defenses, including the cannabidiol treatment preparation defense, and keeps hemp-related exclusions in place for industrial hemp, certain hemp waste, and hemp products.
The bill’s broader impact would be to lower the state-law classification of marijuana and tetrahydrocannabinols and align Kansas’s controlled-substances schedules with a less restrictive treatment of cannabis-related substances. It would affect criminal defendants, law enforcement, prosecutors, and courts by changing the offense level and penalty structure tied to possession. It would also require updates to statutory references in the criminal code and controlled-substances schedules.
There is little recorded public or committee sentiment in the provided materials because there are no transcripts or votes attached to the bill. Based on the bill text and caption, the measure appears to be a policy change aimed at cannabis rescheduling rather than a technical cleanup bill. Because no committee debate or vote history is available, no clear support or opposition can be identified from the record provided.
The main point of contention likely concerns marijuana policy itself: whether cannabis should remain in a highly restricted schedule or be treated more like a lower-risk controlled substance. Supporters would likely view the bill as a modernization and criminal-justice reform measure, while opponents may object to any reduction in penalties or to rescheduling marijuana at all. The bill also implicates related issues such as repeat possession penalties, hemp distinctions, and the treatment of tetrahydrocannabinols and cannabidiol products.
Impact
The bill amends K.S.A. 21-5706 and K.S.A. 65-4109, and K.S.A. 2025 Supp. 65-4105, to move marijuana and tetrahydrocannabinols from Schedule I to Schedule III and to conform related possession and scheduling provisions. This would reduce the severity of Kansas criminal penalties tied to possession of marijuana and tetrahydrocannabinols, alter repeat-offense treatment, and update the state’s controlled-substances schedules and related statutory cross-references. It also preserves hemp exclusions and the cannabidiol treatment preparation affirmative defense.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of legislative sentiment in the materials. The bill’s caption and text indicate a reform-oriented approach to cannabis rescheduling, suggesting likely support from lawmakers favoring reduced marijuana penalties and opposition from those who prefer maintaining stricter controlled-substances treatment. Overall sentiment cannot be measured from the record, but the proposal is clearly substantive and policy-driven rather than technical.
Contention
The central point of contention is the rescheduling of marijuana and tetrahydrocannabinols from Schedule I to Schedule III, which would reduce criminal penalties and change how possession offenses are classified. Supporters would likely argue that Kansas should modernize its drug laws and treat cannabis more proportionally, while opponents may argue that rescheduling weakens drug enforcement and sends the wrong policy signal. Secondary issues include the bill’s effect on repeat-offender enhancements, the continued treatment of hemp and cannabidiol products, and the broader implications for controlled-substances enforcement.